cingal — NDA/BLA submission
2026
Cingal and Hyalofast remain core strategic priorities for 2026 as we prepare for future U.S. market launches.Source filing
ANIKA THERAPEUTICS INC · Data as of 2026-09-08
2026
Cingal and Hyalofast remain core strategic priorities for 2026 as we prepare for future U.S. market launches.Source filing